These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2168999)

  • 1. Complement-mediated, infection-enhancing antibodies in plasma from vaccinated macaques before and after inoculation with live simian immunodeficiency virus.
    Montefiori DC; Murphey-Corb M; Desrosiers RC; Daniel MD
    J Virol; 1990 Oct; 64(10):5223-5. PubMed ID: 2168999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine protection against simian immunodeficiency virus infection.
    Desrosiers RC; Wyand MS; Kodama T; Ringler DJ; Arthur LO; Sehgal PK; Letvin NL; King NW; Daniel MD
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6353-7. PubMed ID: 2548210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of live-attenuated and whole-inactivated simian immunodeficiency virus vaccines against vaginal challenge with virulent SIV.
    Marthas ML; Miller CJ; Sutjipto S; Higgins J; Torten J; Lohman BL; Unger RE; Ramos RA; Kiyono H; McGhee JR
    J Med Primatol; 1992; 21(2-3):99-107. PubMed ID: 1433273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV.
    Marthas ML; Sutjipto S; Higgins J; Lohman B; Torten J; Luciw PA; Marx PA; Pedersen NC
    J Virol; 1990 Aug; 64(8):3694-700. PubMed ID: 2164591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivated simian immunodeficiency virus vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animals.
    Sutjipto S; Pedersen NC; Miller CJ; Gardner MB; Hanson CV; Gettie A; Jennings M; Higgins J; Marx PA
    J Virol; 1990 May; 64(5):2290-7. PubMed ID: 2157886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-dependent enhancement of simian immunodeficiency virus (SIV) infection in vitro by plasma from SIV-infected rhesus macaques.
    Montefiori DC; Robinson WE; Hirsch VM; Modliszewski A; Mitchell WM; Johnson PR
    J Virol; 1990 Jan; 64(1):113-9. PubMed ID: 2152808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Complement-Mediated Lysis of Simian Immunodeficiency Virus (SIV) and SIV-Infected Cells Reveals Sex Differences in Vaccine-Induced Immune Responses in Rhesus Macaques.
    Miller-Novak LK; Das J; Musich TA; Demberg T; Weiner JA; Venzon DJ; Mohanram V; Vargas-Inchaustegui DA; Tuero I; Ackerman ME; Alter G; Robert-Guroff M
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.
    Connor RI; Montefiori DC; Binley JM; Moore JP; Bonhoeffer S; Gettie A; Fenamore EA; Sheridan KE; Ho DD; Dailey PJ; Marx PA
    J Virol; 1998 Sep; 72(9):7501-9. PubMed ID: 9696847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrarectal challenge of macaques vaccinated with formalin-inactivated simian immunodeficiency virus.
    Cranage MP; Baskerville A; Ashworth LA; Dennis M; Cook N; Sharpe S; Farrar G; Rose J; Kitchin PA; Greenaway PJ
    Lancet; 1992 Feb; 339(8788):273-4. PubMed ID: 1346285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus.
    Kumar A; Mukherjee S; Shen J; Buch S; Li Z; Adany I; Liu Z; Zhuge W; Piatak M; Lifson J; McClure H; Narayan O
    Virology; 2002 Sep; 301(2):189-205. PubMed ID: 12359422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivated whole-virus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge.
    Johnson PR; Montefiori DC; Goldstein S; Hamm TE; Zhou J; Kitov S; Haigwood NL; Misher L; London WT; Gerin JL
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2175-9. PubMed ID: 1549578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine-induced neutralizing antibodies directed in part to the simian immunodeficiency virus (SIV) V2 domain were unable to protect rhesus monkeys from SIV experimental challenge.
    Schlienger K; Montefiori DC; Mancini M; Rivière Y; Tiollais P; Michel ML
    J Virol; 1994 Oct; 68(10):6578-88. PubMed ID: 7521918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive immunization of rhesus macaques against SIV infection and disease.
    Gardner M; Rosenthal A; Jennings M; Yee J; Antipa L; Robinson E
    AIDS Res Hum Retroviruses; 1995 Jul; 11(7):843-54. PubMed ID: 7546912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines.
    Israel ZR; Edmonson PF; Maul DH; O'Neil SP; Mossman SP; Thiriart C; Fabry L; Van Opstal O; Bruck C; Bex F
    J Virol; 1994 Mar; 68(3):1843-53. PubMed ID: 8107246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A formalin-inactivated whole SIV vaccine confers protection in macaques.
    Murphey-Corb M; Martin LN; Davison-Fairburn B; Montelaro RC; Miller M; West M; Ohkawa S; Baskin GB; Zhang JY; Putney SD
    Science; 1989 Dec; 246(4935):1293-7. PubMed ID: 2555923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine protection of rhesus macaques against simian immunodeficiency virus infection.
    Carlson JR; McGraw TP; Keddie E; Yee JL; Rosenthal A; Langlois AJ; Dickover R; Donovan R; Luciw PA; Jennings MB
    AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1239-46. PubMed ID: 2078406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of macaques against simian immunodeficiency virus infection with inactivated vaccines: comparison of adjuvants, doses and challenge viruses. The European Concerted Action on 'Macaque Models for AIDS Research'.
    Vaccine; 1995 Feb; 13(3):295-300. PubMed ID: 7631516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of complement-activating antibodies in the SIV/macaque model of acute primary infection and vaccine protection.
    Montefiori DC; Reimann KA; Letvin NL; Zhou J; Hu SL
    AIDS Res Hum Retroviruses; 1995 Aug; 11(8):963-70. PubMed ID: 7492443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel application of nonhuman primate tethering system for evaluation of acute phase SIVmac251 infection in rhesus macaques (Macaca mulatta).
    Keckler MS; Hodara VL; Parodi LM; Giavedoni LD
    Viral Immunol; 2007 Dec; 20(4):623-34. PubMed ID: 18158735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passively transferred antibodies directed against conserved regions of SIV envelope protect macaques from SIV infection.
    Lewis MG; Elkins WR; McCutchan FE; Benveniste RE; Lai CY; Montefiori DC; Burke DS; Eddy GA; Shafferman A
    Vaccine; 1993 Oct; 11(13):1347-55. PubMed ID: 7507625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.